CD36 and cancer: Another carcinogenic modulator, CD36, is a membrane glycoprotein that is associated with elevated fatty acids absorption to modulate cancer progression and metastasis in various cancers such as ovarian (Ladanyi et al., 2018), cervical (Yang P. et al., 2018), liver (Nath et al., 2015), and stomach (Pan et al., 2019).